Prevention of salt-induced hypertension and fibrosis by AT 1-receptor blockers in Dahl S rats

Journal of Cardiovascular Pharmacology

Volumn 51, Issue 5, 2008, Pages 457-466

  Liang, Binhui ^a   Leenen, Frans H H ^a  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

Author keywords

Blood pressure; Fibrosis; High salt diet; Hypertrophy; Losartan; Telmisartan

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN 2 RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE; LOSARTAN; TELMISARTAN; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR ANTAGONIST; BENZIMIDAZOLE DERIVATIVE; BENZOIC ACID DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DAHL SALT SENSITIVE RAT; DRUG RECEPTOR BINDING; HEART HYPERTROPHY; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE FIBROSIS; HEART RIGHT VENTRICLE HYPERTROPHY; HEART WEIGHT; HYPERTENSION; KIDNEY HYPERTROPHY; KIDNEY MASS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SALT INTAKE; ANIMAL; ANTIBODY SPECIFICITY; AORTA; CARDIOMEGALY; DOSE RESPONSE; DRUG EFFECT; FIBROSIS; HEART MUSCLE; HEART RATE; HYPERTROPHY; KIDNEY; METABOLISM; PATHOLOGY; SODIUM INTAKE;

ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; AORTA; BENZIMIDAZOLES; BENZOATES; BLOOD PRESSURE; CARDIOMEGALY; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBROSIS; HEART RATE; HYPERTENSION; HYPERTROPHY; KIDNEY; LOSARTAN; MALE; MYOCARDIUM; ORGAN SPECIFICITY; RATS; RATS, INBRED DAHL; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; SODIUM, DIETARY;

EID: 55949135607     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/FJC.0b013e318169e948     Document Type: Article

References (42)

1. Bayorh MA, Ganafa AA, Emmett N, et al. Alterations in aldosterone and angiotensin II levels in salt-induced hypertension. Clin Exp Hypertens. 2005;27:355-367.
2. Wang JM, Veerasingham SJ, Tan J, et al. Effects of high salt intake on brain AT1 receptor densities in Dahl rats. Am J Physiol Heart Circ Physiol. 2003;285:H1949-H1955.
3. Zhao X, White R, Huang BS, et al. High salt intake and the brain renin-angiotensin system in Dahl salt-sensitive rats. J Hypertens. 2001; 19: 89-98.
4. Huang BS, Leenen FH. Both brain angiotensin II and "ouabain" contribute to sympathoexcitation and hypertension in Dahl S rats on high salt intake. Hypertension. 1998;32:1028-1033.
5. Leenen FH, Yuan B. Prevention of hypertension by irbesartan in Dahl S rats relates to central angiotensin II type 1 receptor blockade. Hypertension. 2001;37:981-984.
6. Nagata K, Somura F, Obata K, et al. AT1 receptor blockade reduces cardiac calcineurin activity in hypertensive rats. Hypertension. 2002;40:168-174.
7. Yayama K, Horii M, Hiyoshi H, et al. Up-regulation of angiotensin II type 2 receptor in rat thoracic aorta by pressure-overload. J Pharmacol Exp Ther. 2004;308:736-743.
8. Kim-Mitsuyama S, Izumi Y, Izumiya Y, et al. Additive beneficial effects of the combination of a calcium channel blocker and an angiotensin blocker on a hypertensive rat-heart failure model. Hypertens Res. 2004; 27:771-779.
9. de Simone G, Devereux RB, Camargo MJ, et al. Reduction of development of left ventricular hypertrophy in salt-loaded Dahl salt-sensitive rats by angiotensin II receptor inhibition. Am J Hypertens. 1996; 9:216-222.
10. Tinel H. Beneficial effects of the combination of nifedipine and losartan in hypertensive Dahl salt-sensitive rats. J Cardiovasc Pharmacol. 2007; 50:75-82.
11. Ranade V, Somberg JC. Rapid determination of partition coefficients between n-octanol/water for cardiovascular therapies. Am J Ther. 2002;9:19-24.
12. Kakuta H, Sudoh K, Sasamata M, et al. Telmisartan has the strongest binding affinity to angiotensin II type 1 receptor: comparison with other angiotensin II type 1 receptor blockers. Int J Clin Pharmacol Res. 2005; 25:41-46.
13. Timmermans PB. Pharmacological properties of angiotensin II receptor antagonists. Can J Cardiol. 1999;15(Suppl):26F-28F.
14. Ruzicka M, Skarda V, Leenen FH. Effects of ACE inhibitors on circulating versus cardiac angiotensin II in volume overload-induced cardiac hypertrophy in rats. Circulation. 1995;92:3568-3573.
15. Huang BS, Ahmad M, Deng AY, et al. Neuronal responsiveness to central Na+ in 2 congenic strains of Dahl salt-sensitive rats. Hypertension. 2007; 49:1315-1320.
16. Dean SA, Tan J, O'Brien ER, et al. 17beta-estradiol downregulates tissue angiotensin-converting enzyme and ANGII type 1 receptor in female rats. Am J Physiol Regul Integr Comp Physiol. 2005;288:R759-R766.
17. Tan J, Wang JM, Leenen FH. Inhibition of brain angiotensin-converting enzyme by peripheral administration of trandolapril versus lisinopril in Wistar rats. Am J Hypertens. 2005;18:158-164.
18. Lal A, Veinot JP, Leenen FH. Prevention of high salt diet-induced cardiac hypertrophy and fibrosis by spironolactone. Am J Hypertens. 2003;16: 319-323.
19. Chan SH, Wang LL, Tseng HL, et al. Upregulation of AT1 receptor gene on activation of protein kinase Cbeta/nicotinamide adenine dinucleotide diphosphate oxidase/ERK1/2/c-fos signaling cascade mediates long-term pressor effect of angiotensin II in rostral ventrolateral medulla. J Hypertens. 2007;25:1845-1861.
20. Gao L, Wang W, Li YL, et al. Sympathoexcitation by central ANG II: roles for AT1 receptor upregulation and NAD(P)H oxidase in RVLM. Am J Physiol Heart Circ Physiol. 2005;288:H2271-H2279.
21. Zhou J, Pavel J, Macova M, et al. AT1 receptor blockade regulates the local angiotensin II system in cerebral microvessels from spontaneously hypertensive rats. Stroke. 2006;37:1271-1276.
22. Schunkert H, Ingelfinger JR, Hirsch AT, et al. Feedback regulation of angiotensin converting enzyme activity and mRNA levels by angiotensin II. Circ Res. 1993;72:312-318.
23. Tamura K, Chiba E, Yokoyama N, et al. Renin-angiotensin system and fibronectin gene expression in Dahl Iwai salt-sensitive and salt-resistant rats. J Hypertens. 1999;17:81-89.
24. Sumida Y, Umemura S, Kobayashi S, et al. Angiotensin II receptors in cardiac left ventricles of Dahl rats. Clin Exp Pharmacol Physiol. 1998;25: 252-256.
25. Schieffer B, Wirger A, Meybrunn M, et al. Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat. Circulation. 1994;89:2273-2282.
26. Weinberg EO, Lee MA, Weigner M, et al. Angiotensin AT1 receptor inhibition. Effects on hypertrophic remodeling and ACE expression in rats with pressure-overload hypertrophy due to ascending aortic stenosis. Circulation. 1997;95:1592-1600.
27. Malhotra R, Sadoshima J, Brosius FC, et al. Mechanical stretch and angiotensin II differentially upregulate the renin-angiotensin system in cardiac myocytes in vitro. Circ Res. 1999;85:137-146.
28. Silvestre JS, Heymes C, Oubenaissa A, et al. Activation of cardiac aldosterone production in rat myocardial infarction: effect of angiotensin II receptor blockade and role in cardiac fibrosis. Circulation. 1999;99: 2694-2701.
29. Takai S, Sakonjo H, Miyazaki M. Beneficial effect of trandolapril on the lifespan of a severe hypertensive model. Hypertens Res. 2001;24: 559-564.
30. Nickenig G, Strehlow K, Roeling J, et al. Salt induces vascular AT1 receptor overexpression in vitro and in vivo. Hypertension. 1998;31: 1272-1277.
31. Bonnet F, Cooper ME, Carey RM, et al. Vascular expression of angiotensin type 2 receptor in the adult rat: influence of angiotensin II infusion. J Hypertens. 2001;19:1075-1081.
32. Zhou MS, Adam AG, Jaimes EA, et al. In salt-sensitive hypertension, increased superoxide production is linked to functional upregulation of angiotensin II. Hypertension. 2003;42:945-951.
33. Sharifi AM, Akbarloo N, Darabi R. Investigation of local ACE activity and structural alterations during development of L-NAME-induced hypertension. Pharmacol Res. 2005;52:438-444.
34. Harrison-Bernard LM, Zhuo J, Kobori H, et al. Intrarenal AT(1) receptor and ACE binding in ANG II-induced hypertensive rats. Am J Physiol Renal Physiol. 2002;282:F19-F25.
35. Uhlenius N, Vuolteenaho O, Tikkanen I. Renin-angiotensin blockade improves renal cGMP production via non-AT(2)-receptor mediated mechanisms in hypertension-induced by chronic NOS inhibition in rat. J Renin Angiotensin Aldosterone Syst. 2001;2:233-239.
36. Yoshihara F, Suga S, Yasui N, et al. Chronic administration of adrenomedullin attenuates the hypertension and increases renal nitric oxide synthase in Dahl salt-sensitive rats. Regul Pept. 2005;128:7-13.
37. Huang BS, Van Vliet BN, Leenen FH. Increases in CSF [Na+] precede the increases in blood pressure in Dahl S rats and SHR on a high-salt diet. Am J Physiol Heart Circ Physiol. 2004;287:H1160-H1166.
38. Brown DR, Morgan DA, Peuler MJ, et al. 24-Hour blood pressure recordings in Dahl rats on high- and low-salt diets. Am J Physiol Regul Integr Comp Physiol. 1989;26:R1225-R1231.
39. Mohri T, Emoto N, Nonaka H, et al. Alterations of circadian expressions of clock genes in Dahl salt-sensitive rats fed a high-salt diet. Hypertension. 2003;42:189-194.
40. Yamamoto K, Mano T, Yoshida J, et al. ACE inhibitor and angiotensin II type 1 receptor blocker differently regulate ventricular fibrosis in hypertensive diastolic heart failure. J Hypertens. 2005;23:393-400.
41. Liang B, Leenen FHH. Prevention of salt induced hypertension and fibrosis by ACE inhibitors in Dahl S rats. Br J Pharmacol. 2007;152: 903-914.
42. Bledsoe G, Shen B, Yao Y, et al. Reversal of renal fibrosis, inflammation, and glomerular hypertrophy by kallikrein gene delivery. Hum Gene Ther. 2006;17:545-555.